Cancer immunotherapy research holds great promise for better understanding various cancer types, as well as infectious disease, and immunodeficiencies. As the field evolves to clinical research, more sophisticated and standardized culturing tools are required. Specifically, raw material traceability, therapeutic-grade media endorsed by regulatory bodies, and documentation become increasingly important.
Thermo Fisher Scientific provides a portfolio of products for Cancer Immunotherapy research —designed for the efficient isolation, activation, and culture of various types of immune cells. These products are manufactured in compliance with ISO 9001and ISO13485 standards. Products are supplied with a certificate of analysis, origin, and access to authorization letters for our Drug Master Files (DMF).